Ulipristal Acetate 30 mg Tablets

Ulipristal acetate is a selective progesterone receptor modulator that binds with high affinity to progesterone receptors. In emergency contraception it delays or inhibits ovulation and may alter endometrial receptivity. In fibroid therapy it reduces fibroid volume and controls bleeding by modulating progesterone activity.

Emergency contraception within 120 hours (5 days) of unprotected intercourse or contraceptive failure; and pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

For emergency contraception: a single 30 mg tablet taken as soon as possible within 120 hours of unprotected intercourse. For fibroid therapy: one 30 mg tablet daily for up to 3 months, as directed by a physician.

Swallow the tablet whole with water, with or without food. For emergency contraception, take as soon as possible after unprotected intercourse. If vomiting occurs within 3 hours, take a replacement dose.

Adult women of reproductive age. Not for use during pregnancy or breastfeeding. Not intended for use as a regular contraceptive. Use with caution in hepatic impairment and in women with severe asthma.

Common: headache, nausea, abdominal pain, menstrual changes (delayed menstruation, spotting), dizziness, fatigue. Less common: hot flushes, breast tenderness, mood changes.

Pregnancy; breastfeeding; hypersensitivity to ulipristal acetate; severe hepatic impairment; genital bleeding of unknown cause or for reasons other than fibroids.

Store below 25°C in original packaging. Protect from moisture and light. Keep out of reach of children.